Evidence map›Paper›PMID 41865168›Full record

ArticleScientific reports2026

Impact of comorbid diseases and associated factors on tuberculosis treatment outcomes among tuberculosis patients in South West Oromia, Ethiopia: a retrospective cohort study.

Gemechu Gelana Ararame, Birbirsa Sefera Senbeta, Tesfaye Negesa Liche, Elias Zewdu Sileshi

Abstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gemechu Gelana ArarameDepartment of Pharmacy, College of Health Science, Mattu University, Mattu, Oromia, Ethiopia. gammeegalaanaa@gmail.com.
Birbirsa Sefera SenbetaDepartment of Pharmacy, College of Health Science, Mattu University, Mattu, Oromia, Ethiopia.
Tesfaye Negesa LicheDepartment of Pharmacy, College of Health Science, Mattu University, Mattu, Oromia, Ethiopia.
Elias Zewdu SileshiDepartment of Pharmacy, College of Health Science, Mattu University, Mattu, Oromia, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Comorbid diseases are complex diseases associated with tuberculosis that may affect tuberculosis treatment outcomes and mortality. The impact of comorbid diseases on tuberculosis treatment outcomes and mortality is not well known in Ethiopia. To assess the impact of comorbid diseases and associated factors on tuberculosis treatment outcomes among tuberculosis patients in Southwest Oromia, Ethiopia. A multicenter retrospective cohort study was performed. Information on sociodemographic, clinical conditions, drug-related factors, and treatment outcomes was extracted. The collected data were entered into Epi-Data version 4.6 for data entry and exported to SPSS version 25 (IBM Corp., Armonk, NY, USA) for statistical analysis. Independent t-tests were used for continuous variables and chi-square for categorical variables for comparison of the tuberculosis patients with and without comorbid disease groups. Univariate and multivariate logistic regression were used for outcomes analysis. Statistical significance was determined at a p-value < 0.05 in multivariate logistic regression. Among a total of 1183 tuberculosis patients, females were 825(69.8%), and the mean age of the patients was 40.17 with a standard deviation of ± 16.02. The prevalence of unsuccessful tuberculosis treatment outcomes was 14.29%. Treatment interruption, death, and treatment failure among tuberculosis patients were 1.35%, 7.10%, and 5.83%, respectively. Comorbid diseases were a significant risk factor for unsuccessful tuberculosis treatment outcome (adjusted relative risk (RR) = 3.198, 95% CI 1.755-4.901), P < 0.001). Additionally, age (RR = 1.057, 95% CI 1.036-1.078, p < 0.001), being male (RR = 2.026, 95% CI 1.361-3.016, p = 0.001), living in rural areas (RR = 3.092, 95% CI 2.038-4.691, p < 0.001), and Charlson comorbidity index scores (1, 2, and ≥ 3) were independent predictors of unsuccessful tuberculosis treatment outcome. This study revealed that the prevalence of unsuccessful tuberculosis treatment outcomes was high. Comorbid diseases, Charlson comorbidity index scores (1, 2, and ≥ 3), age, being male, and living in rural areas were predictors for unsuccessful tuberculosis treatment outcome. It is important to implement an integrated management strategy for both tuberculosis and comorbid diseases to reduce the rate of unsuccessful tuberculosis treatment outcomes.

Indexed as

Antitubercular AgentsTuberculosisAdolescentAdultComorbidityEthiopiaFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsTreatment OutcomeYoung AdultAntitubercular AgentsComorbid diseaseImpactTreatment outcomeTuberculosis

Identifiers

PMID41865168
PMCPMC13144491

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.